Drug Target Review2025-01-16T08:00:30
UVA Center for Diabetes Technology and Tandem Diabetes Care partner to advance automated insulin delivery systems for diabetes management.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-18T11:12:00Z
2026-11-18T07:00:00Z
Contributor Dr Bryan McClellan and Dr William Matsui, Drug Target Review
2026-11-16T07:00:00Z
Author Dr Martin Baraibar
2023-04-12T15:28:08
Sponsored by nanoComposix
2023-02-23T14:02:18
Sponsored by bit.bio
2026-08-24T08:43:00
Author Dr Dana Watt
2026-10-28T16:21:00
Contributor Dr Sonal Gupta and Dr David Lonard, Drug Target Review
2026-05-22T07:38:00
Contributor Dr Helen Bright, Drug Target Review
Site powered by Webvision Cloud